crataegus oxyacantha stem extract
extract of the stems of the hawthorn, crataegus oxycantha (l.), rosaceae
Identification
| Name | crataegus oxyacantha stem extract |
| IUPAC | crataegus extract |
| FDA UNII | Search |
Regulatory
Physical Properties
| Food Chemicals Codex Listed | No |
Cosmetic Information
| CosIng | cosmetic data |
| Cosmetic Uses | antimicrobial agents |
No sensory data available
Safety Information
| Oral/Parenteral Toxicity | Not determined |
| Dermal Toxicity | Not determined |
| Inhalation Toxicity | Not determined |
GHS Classification
['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']
Safety in Use
| Category | antimicrobial agents |
| Recommendation for crataegus oxyacantha stem extract usage levels up to | not for fragrance use. |
| Recommendation for crataegus oxyacantha stem extract flavor usage levels up to | not for flavor use. |
No supplier data available
Potential Uses
Natural Occurrence
Synonyms
crataegus curvisepala stem extract
extract of the stems of the hawthorn, crataegus oxycantha (l.), rosaceae
hawthorn stem extract
hawthorne stem extract
PubMed:
Effect of Crataegus Usage in Cardiovascular Disease Prevention: An Evidence-Based Approach.
PubMed:
Phytochemical attributes of four conventionally extracted medicinal plants and cytotoxic evaluation of their extracts on human laryngeal carcinoma (HEp2) cells.
PubMed:
Combined HPLC-DAD-MS, HPLC-MS(n) and NMR spectroscopy for quality control of plant extracts: the case of a commercial blend sold as dietary supplement.
PubMed:
Hawthorn (Crataegus oxyacantha L.) bark extract regulates antioxidant response element (ARE)-mediated enzyme expression via Nrf2 pathway activation in normal hepatocyte cell line.
PubMed:
Anti-microbial and anti-oxidant activities of Illicium verum, Crataegus oxyacantha ssp monogyna and Allium cepa red and white varieties.
PubMed:
Anti-inflammatory and anti-apoptotic effects of Crataegus oxyacantha on isoproterenol-induced myocardial damage.
PubMed:
Hawthorn--Crataegus monogyna (common hawthorn) or Crataegus laevigata (midland hawthorn; Crataegus oxyacantha); also known as haw, thornapple, maythorn, whitethorn.
PubMed:
Immunomodulatory effect of Hawthorn extract in an experimental stroke model.
PubMed:
Crataegus oxyacantha (Hawthorn). Monograph.
PubMed:
Preclinical toxicological assessment of a phytotherapeutic product--CPV (based on dry extracts of Crataegus oxyacantha L., Passiflora incarnata L., and Valeriana officinalis L.).
PubMed:
Synergistic effect of tincture of Crataegus and Mangifera indica L. extract on hyperlipidemic and antioxidant status in atherogenic rats.
PubMed:
Anti-inflammatory, gastroprotective, free-radical-scavenging, and antimicrobial activities of hawthorn berries ethanol extract.
PubMed:
[An orientational examination of the effects of extracts from mixtures of herbal drugs on selected renal functions].
PubMed:
Evaluation of the content and stability of the constituents of mother tinctures and tinctures: the case of Crataegus oxyacantha L. and Hieracium pilosella L.
PubMed:
[Crataegus oxyacantha (aubepine) in the use as herb medicine in France].
PubMed:
Hawthorn evokes a potent anti-hyperglycemic capacity in streptozotocin-induced diabetic rats.
PubMed:
Double-blind, randomised, placebo-controlled study to evaluate the efficacy and safety of a fixed combination containing two plant extracts (Crataegus oxyacantha and Eschscholtzia californica) and magnesium in mild-to-moderate anxiety disorders.
PubMed:
A randomised double blind placebo controlled clinical trial of a standardised extract of fresh Crataegus berries (Crataegisan) in the treatment of patients with congestive heart failure NYHA II.
PubMed:
Interaction study between digoxin and a preparation of hawthorn (Crataegus oxyacantha).
PubMed:
Hawthorn: pharmacology and therapeutic uses.
PubMed:
Search for potential angiotensin converting enzyme (ACE)-inhibitors from plants.
PubMed:
Effect of long-term application of Crataegus oxyacantha on ischemia and reperfusion induced arrhythmias in rats.
PubMed:
Antioxidants in medicinal plant extracts. A research study of the antioxidant capacity of Crataegus, Hamamelis and Hydrastis.
PubMed:
Procyanidins in crataegus extract evoke endothelium-dependent vasorelaxation in rat aorta.
PubMed:
Protective effect of Crataegus oxyacantha against reperfusion arrhythmias after global no-flow ischemia in the rat heart.
PubMed:
Crataegus oxyacantha and heart failure.
PubMed:
Effect of tincture of Crataegus on the LDL-receptor activity of hepatic plasma membrane of rats fed an atherogenic diet.
PubMed:
Myocardial protection by pretreatment with Crataegus oxyacantha: an assessment by means of the release of lactate dehydrogenase by the ischemic and reperfused Langendorff heart.
PubMed:
Inhibition of thromboxane A2 biosynthesis in vitro by the main components of Crataegus oxyacantha (Hawthorn) flower heads.
PubMed:
Hypolipidemic activity of tincture of Crataegus in rats.
PubMed:
[Valeriana officinalis and Crataegus oxyacantha: toxicity from repeated administration and pharmacologic investigations].
PubMed:
High-performance liquid chromatography of flavonoids in Crataegus oxyacantha L. IV. Reversed-phase high-pressure liquid chromatography in flower, leaf and bud extractives of Crataegus oxyacantha L.
PubMed:
High-performance liquid chromatography and diffuse reflectance spectroscopy of flavonoids in Crataegus oxyacantha L. III--Analysis of 2-phenyl-chroman derivatives and caffeic acid.
PubMed:
Analysis of 2-phenyl-chromon derivatives and chlorogenic acid. II. High-performance thin layer chromatography and high-performance liquid chromatography in flowers, leaves and buds extractives of Crataegus oxyacantha L.
PubMed:
High-performance liquid chromatography of flavonoids in Crataegus oxyacantha L. I. Reversed-phase high-pressure liquid chromatography.
PubMed:
[Cardioactive drugs IV. Cardiotonic amines from Crataegus oxyacantha (author's transl)].
PubMed:
[Evaluation of the activity on the mouse CNS of several plant extracts and a combination of them].
PubMed:
[Comparative study of flavonoids form Crataegus oxyacantha L. and Crataegus monogyna Jacq].
PubMed:
[Predictability of the activity of drug combinations--yes or no (author's transl)].
PubMed:
[Pharmacological properties of oligomeric procyanidine isolated from hawthorn (Crataegus oxyacantha)].
PubMed:
[Some pharmacological properties of flavan polymers isolated from hawthorn (Crataegus oxyacantha)].
PubMed:
[On the effect of highly condensed flavans on the heart. With a contribution to the problem of the effect of Crataegus oxyacantha].
PubMed:
[Clinical experiences with the intravenous administration of hawthorn (Crataegus oxyacantha) in myocardial infarct].
PubMed:
[Preparation and pharmacological research on a new therapeutic agent from Crataegus oxyacantha].
PubMed:
[Effect of Crataegus oxyacantha extracts on certain Protozoa].
PubMed:
[Effect of Crataegus oxyacantha extract on the coronary blood flow in dogs].
PubMed:
[Electrocardiographic effects of a Crataegus oxyacantha extract].
PubMed:
[Clinical and experimental studies on the effectiveness of hawthorn (Crataegus oxyacantha)].
PubMed:
[Medicinal herbs (Crataegus oxyacantha)].
PubMed:
[Experience with an injectable preparation of Crataegus oxyacantha].
PubMed:
[Animal experiments on the action of Crataegus oxyacantha L].
PubMed:
[Therapy of heart diseases with Crataegus oxyacantha and Sarothamnus scoparius].
PubMed:
[New ingredients from Crataegus oxyacantha; flavone derivatives].
PubMed:
[Absence of digitaloids in Crataegus oxyacantha. III. Constituents of hawthorn].
PubMed:
[Ingredients of Crataegus oxyacantha L. III. Heptahydroxyflavan glycoside].
PubMed:
Crataegus Oxyacantha in Hypertension.